Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Academic Pediatrics|April 22, 2026
Cardiovascular Risk Factors and Health-Related Social Needs among Youth in a Largely Rural Health SystemCatherine P Benziger, Brandon J Schultz, Melissa L Harry, et al.
Plos One|July 7, 2011
Unraveling a 146 years old taxonomic puzzle: validation of Malabar snakehead, species-status and its relevance for channid systematics and evolutionAllen Benziger, Siby Philip, Rajeev Raghavan, et al.
Plos Pathogens|September 26, 2018
Correction: Viral FGARAT ORF75A promotes early events in lytic infection and gammaherpesvirus pathogenesis in miceNick D Van Skike, Nana K Minkah, Chad H Hogan, et al.
Journal of the American Heart Association|November 26, 2025
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLEChristopher L Mosher, Amanda Stebbins, Courtney E Lamberton, et al.
Plos Pathogens|February 2, 2018
Viral FGARAT ORF75A promotes early events in lytic infection and gammaherpesvirus pathogenesis in miceNick D Van Skike, Nana K Minkah, Chad H Hogan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adultsD M Cook, B M K Biller, M L Vance, et al.
Vascular Medicine (London, England)|April 7, 2023
Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) studyE Hope Weissler, Amanda Stebbins, Lisa Wruck, et al.
Clinical Trials (London, England)|February 5, 2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trialAjar Kochar, Mary B Summers, Catherine P Benziger, et al.
Plos One|January 5, 2022
Dry heat sterilization as a method to recycle N95 respirator masks: The importance of fitJohn G Yuen, Amy C Marshilok, Peter Todd Benziger, et al.
BMJ Open|August 8, 2024
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trialGuillaume Marquis-Gravel, Hillary Mulder, Lisa M Wruck, et al.
Pageof 15